A Phase 1, Randomized, Double-Blind, Cross-Over, Placebo- and Active-Controlled Cardiac Safety Study of Therapeutic and Supratherapeutic Doses of Fumaryl Diketopiperazine Administered as Technosphere® Inhalation Powder in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2012
At a glance
- Drugs Insulin; Moxifloxacin
- Indications Bacterial infections; Diabetes mellitus
- Focus Adverse reactions
- Sponsors MannKind Corporation
- 29 Jun 2011 Results will be presented at ADA-2011 according to a MannKind Corporation media release. Results were also summarised in the media release.
- 29 Jun 2011 New trial record
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.